Buy the Dip in These 3 Healthcare Stocks Right Now

Asia's Tech News Daily

A confluence of the widespread adoption of digital innovations, accelerating developments in therapeutics, and rising healthcare spending should propel the healthcare sector’s growth. Therefore, we think the recent price dips in fundamentally sound healthcare stocks Pfizer (PFE), Abbott Laboratories (ABT), and Agilent Technologies (A) provide a perfect buying opportunity. So, read on.

 registering a 4% CAGR ,  POWR Ratings , Click here ,    Medical – Pharmaceuticals ,  operating earnings ,  Medical – Diagnostics/Research ,  Learn more here,  earning a master's degree in economics

shutterstock.com – StockNews

An aging population, improvements in drugs and therapeutics to treat chronic diseases, the integration of advanced technologies, and rising healthcare spending should propel the healthcare sector’s growth. Furthermore, the growing trend of preventive healthcare, which has been accelerated by the COVID-19 pandemic, bodes well for healthcare providers.

According to a Monthly National Health Spending report, expenditure increased 6.3% year-over-year to $4.09 trillion in September 2021. Also, with high GDP growth, health spending now accounts for nearly 17.5% of GDP. The global healthcare and pharma market is expected to reach $1.58 trillion by 2027, registering a 4% CAGR.  And investors’ interest in the healthcare sector is evident in the Health Care Select Sector SPDR Fund’s (XLV) 16.8% gains year-to-date.

Therefore, fundamentally strong healthcare stocks Pfizer Inc. (PFE), Abbott Laboratories (ABT), and Agilent Technologies, Inc. (A), which have suffered price declines lately, could be ideal picks now.

Click here to checkout our Healthcare Sector Report for 2021

Pfizer Inc. (PFE)

New York City-based PFE is a global biopharmaceutical company that discovers, develops, manufactures, and distributes medicines and vaccines in a wide range of therapeutic areas. The company markets its products under the Eliquis, Xtandi, Medrol, Premarin family, and various other brands. In addition, PFE is involved in the contract manufacturing business and serves retailers, hospitals, government agencies, and disease control and prevention centers.

This month, PFE acquired Trillium Therapeutics, a clinical-stage immuno-oncology company that develops therapies to treat cancer. Through this acquisition, PFE could enhance its oncology portfolio with the addition of next-generation investigational immuno-therapeutics for hematological malignancies.

PFE’s revenues increased 134.4% year-over-year to $24.09 billion in its fiscal third quarter, ended October 3, 2021. The company’s adjusted income grew 132.7% from its  year-ago value to $7.69 billion. Its adjusted EPS rose 127.1% from the prior-year quarter to $1.34. Also, the company’s revenues under the Oncology segment increased 11.7% year-over-year to $3.09 billion.

Analysts expect PFE’s revenue for its fiscal year 2022 to be $782.07 billion, representing 6.4% growth year-over-year. The company has an impressive earnings surprise history; it beat the consensus EPS estimates in three of the trailing four quarters. Its EPS is expected to grow 16.3% next year. The stock has gained 50.6% in price over the past nine months. It is currently trading 3.3% below its 52-week high of $52.84, which it hit on November 19, 2021.

PFE’s strong fundamentals are reflected in its POWR Ratings. The stock has an overall A rating, which equates to a Strong Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 distinct factors, each with its own weighting.

Also, the stock has an A grade for Growth, and a B grade for Value and Quality. We have also graded PFE for Stability, Sentiment, and Momentum. Click here to access all PFE’s ratings.

PFE is ranked #10 of 198 stocks in the Medical – Pharmaceuticals industry.

Abbott Laboratories (ABT)

ABT discovers, develops, manufactures, and sells a diversified line of health care products. The Abbott Park, Ill.-based company operates through four segments: Established Pharmaceutical Products; Diagnostic Products; Nutritional Products; and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart devices, diabetes care products, and neuromodulation devices. ABT markets its products under PediaSure, Ensure, FreeStyle, Glucerna, and various other brands.

This month, ABT launched Similac 360 Total Care, the company’s next generation of infant formula with HMOs. Similac 360 Total Care contains a blend of five different HMOs designed to provide nutrition to support an infant’s health and development. During the third quarter, ended September 30, 2021, ABT’s net sales increased 23.4% year-over-year to $10.93 billion. The company’s operating earnings grew 70.3% from their year-ago value to $2.55 billion. Its net earnings rose 70.5% from the prior-year quarter to $2.1 billion. Also, the company’s EPS increased 42.9% year-over-year to $1.4.

ABT’s revenue is expected to increase 21.8% year-over-year to $42.16 billion in its fiscal year 2021. The company has an impressive earnings surprise history; it surpassed the consensus EPS estimates in each of the four trailing quarters. Its EPS is expected to increase 38.9% in the current year. The stock has gained 13.7% in price year-to-date and is trading 5.4% below its 52-week high of $131.6, which it hit on November 16, 2021.

ABT’s POWR Ratings reflect this promising outlook. The stock has an overall A rating, which equates to a Strong Buy in our proprietary rating system. Also, the stock has a B grade for Sentiment, Quality, and Stability.

In addition to the POWR Rating grades I’ve just highlighted, one can see ABT’s ratings for Value, Momentum, and Growth here. The stock is ranked #12 in the  Medical – Pharmaceuticals industry.

Agilent Technologies, Inc. (A)

Incorporated in 1999, A is a global provider of life sciences, diagnostics, and applied chemical solutions. The Santa Clara, Calif., company provides laboratories with instruments, services, consumables, applications, and expertise. A operates through The Life Sciences and Applied Markets; The Diagnostics and Genomics; The Agilent CrossLab segments.

Last month, A announced that its PD-L1 IHC 22C3 pharmDx could be used to identify TNBC patients for treatment with KEYTRUDA in Europe. KEYTRUDA is a humanized monoclonal antibody that enhances the ability of the immune system to detect and fight tumor cells. By expanding PD-L1 IHC 22C3 pharmDx, A could strengthen its role in developing companion diagnostics for targeted therapies.

A’s net revenue increased 11.9% year-over-year to $1.66 billion for its fiscal fourth quarter, ended October 31, 2021. The company’s income from operations grew 32.1% from its year-ago value to $395 million. Its net income rose 99.1% from the prior-year quarter to $442 million. Also, the company’s EPS increased 104.2% year-over-year to $1.45.

Analysts expect A’s revenue to increase 7.1% year-over-year to $6.02 billion in its fiscal 2022. The company has beaten the consensus EPS in each of the trailing four quarters. Its EPS is expected to increase 11.7% in the current year. A’s stock price has surged 37.9% in price over the past year. It is currently trading 13.8% below its 52-week high of $179.57, which it hit on September 3, 2021.

It is no surprise that A has an overall A rating, which equates to a Strong Buy in our POWR Rating system. Also, the stock has a B grade for Growth, Sentiment, Stability, and Value.

Click here to see the additional POWR Ratings for A (Momentum and Quality). A is ranked #2 of 54 stocks in the Medical – Diagnostics/Research industry.

Note that A is one of the few stocks handpicked by our Chief Growth Strategist, Jaimini Desai, currently in the POWR Growth portfolio. Learn more here.

Click here to checkout our Healthcare Sector Report for 2021


PFE shares fell $0.21 (-0.41%) in premarket trading Wednesday. Year-to-date, PFE has gained 43.80%, versus a 26.02% rise in the benchmark S&P 500 index during the same period.



About the Author: Priyanka Mandal


 registering a 4% CAGR ,  POWR Ratings , Click here ,    Medical – Pharmaceuticals ,  operating earnings ,  Medical – Diagnostics/Research ,  Learn more here,  earning a master's degree in economics

Priyanka is a passionate investment analyst and financial journalist. After earning a master’s degree in economics, her interest in financial markets motivated her to begin her career in investment research.

More…

The post Buy the Dip in These 3 Healthcare Stocks Right Now appeared first on StockNews.com

Internet Explorer Channel Network
Asia's Tech News Daily
News Related

OTHER NEWS

Tega Industries mops up Rs 185.76 crore from anchor investors ahead of IPO

Representative image Tega Industries, the leading polymer-based mill liners producer, on November 30, mobilised Rs 185.76 crore from 25 anchor investors ahead of its initial public offering (IPO) for other ... Read more »

Want Your Charitable Donation to Actually Help Someone? 4 Questions to Ask Before You Give

U.S. wealth grew by $19 trillion since the start of the pandemic. Simultaneously, the pandemic pushed 150 million more people into poverty. This was the first increase in over two decades. ... Read more »

6 key actions to focus a team

Sometimes it is believed that the attitude is enough or that the desire is enough to achieve the results that are proposed. Thus, more than one leader trusts that having ... Read more »

'It's Just Human Nature:' A New Book Examines Why Our Work Is Better When We Work Less

In 2017, reporters Anne Helen Petersen and Charlie Warzel moved from New York City to Missoula, Mont., and started asking some existential questions. The couple — who both wrote for ... Read more »

3 Ways to Supercharge Your Time and Be More Productive Than Ever

Everyone has 24 hours in a day, but some people work harder at maximizing their time than others. Nasdaq CEO Bob Greifeld, for instance, changes clothes in his car. Inventor ... Read more »

The Man Running Govt's Own Startup

Starting Invest India was the most satisfying part of Deepak Bagla’s professional journey. The nodal agency which began in 2015 started functioning in 2016 effectively. In the words of Bagla, ... Read more »

Compensation for crumbling homes to cost Ireland 2.2 billion euros

A new development under construction on Dominick Street Lower, faces old council flats in Dublin DUBLIN (Reuters) – Ireland will provide 2.2 billion euros ($2.5 billion) to help repair or ... Read more »

FBI can gain ‘limited' access to private WhatsApp and Apple iMessage conversations, document claims

(AFP via Getty Images) A new document from the Federal Bureau of Investigation has revealed the extent of the data they can collect from the most popular messaging apps like ... Read more »

Entrepreneurial Burnout: 6 Ways to Avoid And Overcome It

Burnout became an especially painful issue during the pandemic when the majority of people worked from home, finding it difficult to draw the line between work and private life. However, ... Read more »

ViacomCBS to sell iconic Studio Center for $1.85 billion

FILE PHOTO: ViacomCBS headquarters in New York, New York (Reuters) – ViacomCBS Inc, said on Tuesday it would sell CBS Studio Center, where the iconic sitcom “Seinfeld” was shot, for ... Read more »

WTO seeks deals in early 2022 despite postponing major meeting

A logo is pictured on the WTO in Geneva GENEVA (Reuters) – The World Trade Organization should be able to wrap up negotiations on fishing subsidies and a response to ... Read more »

Forget the "New Normal." There's No Normal in Marketing.

Over the past 18 months, companies navigating the pandemic have dealt with numerous changes to seemingly every facet of work. Beyond shifts in daily routines, work lives, and social behavior, ... Read more »

This Crypto-Fueled Internet Collective Raised More Than $40 Million to Buy a Rare Copy of the Constitution

The United States Constitution is more than just another document: It’s the foundation upon which this entire country has been built. In the most significant possible sense, it’s what attempts to ... Read more »

2022 Honda Civic Si First Drive: Straying From The Formula

© Motor1.com 2022 Honda Civic Si First Drive Despite offering less power, the latest Si remains a fun, affordable sedan with tons of charm. Since its introduction in 1984, the ... Read more »

Inflation in eurozone soars to 4.9% – highest on record

Photograph: François Lenoir/Reuters Some investors accuse European Central Bank to allow inflation to run out of control Inflation across the 19-member eurozone soared to 4.9% this month, outstripping City forecasts ... Read more »

Your Top 4 Questions About 2022, Answered By the World's Top Superforecasters

You may have read our story about the forecasting company Good Judgment and its worldwide team of superforecasters. We wanted to put their expertise to use for our readers, so we asked ... Read more »

You Can't Do Everything. So Do the Best With What You Have.

Repeat after me: “I will do the best work with the resources available.” Nigel Parry This has become my mantra. It isn’t sexy. It doesn’t make for a great motivational ... Read more »

Why Jim Cramer Thinks Small Business Owners Can Do More Hiring Than Firing In 2022

When I look at small, private businesses,” says Jim Cramer, “I love to hear expansion plans. It is so exciting to me to hear expansion plans.” He believes the future ... Read more »

Meet the Elite Team of Superforecasters Who Have Turned Future-Gazing Into a Science

Before January 1, 2022, will the United States Olympic Committee announce that it is boycotting the 2022 Olympics? Nicolás Ortega I am in a virtual workshop that will test my ... Read more »

5 Things the Future Holds, According to the World's Most Elite Superforecasters

You may have read our story about the forecasting company Good Judgment and its worldwide team of superforecasters. Now it’s time to put them to the test. Nicolás Ortega Their crystal ball ... Read more »

Ofgem chief Brearley: Energy suppliers need to be more resilient

The UK’s energy suppliers need to be more resilient, the boss of Ofgem has said after more than two dozen companies collapsed in the last three months. Jonathan Brearley also ... Read more »

Subscribe to Star Health and Allied Insurance Company: Choice Equity Broking

Choice Equity Broking IPO report on Star Health and Allied Insurance Company Backed by Rakesh Jhunjhunwala and India’s first pure-play health insurance company, Star Health and Allied Insurance Company Ltd. ... Read more »

Here's why unemployment claims hit their lowest level since 1969

Recruiters speak with potential applicants during a job fair in Leesburg, Virginia, on Oct. 21, 2021. ANDREW CABALLERO-REYNOLDS | AFP | Getty Images Claims for unemployment benefits dipped to their ... Read more »

Ofgem promises tougher stress tests for energy suppliers

Photograph: Rosemary Roberts/Alamy Regulation will need to ‘go much further’ following string of provider collapses, says regulator The energy regulator has promised to put in place tougher stress tests for ... Read more »

Amazon Prime Video's Premier League fixtures and how to access them

Tonight marks the start of Amazon Prime Video’s Premier League coverage for the 2021/22 season. Two of 10 matches will take place tonight, Tuesday November 30, with the remaining eight ... Read more »

Exclusive-Shell eyes return to Libya with oil, gas, solar investments

FILE PHOTO: A logo for Shell is seen on a garage forecourt in central London By Ron Bousso LONDON (Reuters) – Royal Dutch Shell is considering a return to Libya ... Read more »

BoE's Mann says Omicron could hit consumer confidence

FILE PHOTO: People walk past the Bank of England, in London LONDON (Reuters) – BoE policymaker Catherine Mann said on Tuesday that the newly detected Omicron coronavirus variant could hit ... Read more »

6 Key Questions You Should Always Ask Before Investing in a Commercial Real-Estate Property

Commercial real estate is one of the most reliable investment opportunities. Many people build long-term wealth through their property investments. Cyrus McCormick, one of the wealthiest Chicagoans in history, made ... Read more »

The Use Of Recycled Plastics In Packaging Of Food And Drinks Needs To Be Re-Deliberated: Experts

LawWiser, India’s first video-only knowledge-sharing platform for the legal community, today released a consultation paper on ‘The Dilemma of Recycling Plastics in India’. The objective of this consultation paper is ... Read more »

TSB to close quarter of branches in ‘another hammer blow' to UK high street

Photograph: Neil Hall/Reuters TSB Bank is closing a further 70 branches – a quarter of its network – in a move described by campaigners as “yet another hammer blow” to ... Read more »

Base rate and mortgages: all eyes on December

Unsplash ( ) While the Bank of England base rate remains at steady low of 0.1%, the prospect of continued rock-bottom interest rates is fast diminishing. Inflation – as measured ... Read more »

Factbox-Key ECB comments in lead up to crucial Dec 16 meeting

FILE PHOTO: ECB President Lagarde takes part in a news conference, in Frankfurt FRANKFURT (Reuters) – The following are key comments by ECB policymakers in the run up to a ... Read more »

Waiting to talk finance with an aging parent in cognitive decline is a mistake, experts say

Camille Tokerud Photography Inc. | Stone | Getty Images Your elderly mother is getting forgetful and confused. What do you do now? “Waiting until a senior's decline is evident may ... Read more »

Freetrade launching in Europe: Will it become top dog?

© Provided by This Is Money MailOnline logo Viktor Nebehaj’s first encounter with Freetrade came via a Crowdcube funding campaign. In a bold move, he emptied his bank accounts to ... Read more »

Triterras (TRIT) Sees Hammer Chart Pattern: Time to Buy?

Triterras, Inc. TRIT has been struggling lately, but the selling pressure may be coming to an end soon. That is because TRIT recently saw a Hammer Chart Pattern which can ... Read more »

Is It Good Public Policy to Prop Up the Stock Market?

Should policymakers prop up the stock market when it appears to be in danger of crashing down? PIX1861 / Pixabay – Valuewalk Q3 2021 hedge fund letters, conferences and more ... Read more »

SM Energy (SM) Sees Hammer Chart Pattern: Time to Buy?

SM Energy Company SM has been struggling lately, but the selling pressure may be coming to an end soon. That is because SM recently saw a Hammer Chart Pattern which ... Read more »

Bull of the Day: Tyson Foods (TSN)

Tyson Foods (TSN) is a Zacks #1 (Strong Buy) that is the biggest U.S. chicken company. Tyson produces, distributes and markets chicken, beef, pork as well as prepared foods. – ... Read more »

4 Grocery Stocks to Buy as Omicron Variant Raises Fresh Fears

The coronavirus pandemic is far from over. Just when people were feeling confident after vaccination and stepping out of their homes or planning vacations, the Omicron variant of the coronavirus ... Read more »

Bear of the Day: Cracker Barrel Old Country Store (CBRL)

Cracker Barrel (CBRL) is a Zacks Rank #5 (Strong Sell) that is engaged in the ownership and operation of full-service restaurants with a restaurant and a retail store in the ... Read more »
On free-english-test.com you will find lots of free English exam practice materials to help you improve your English skills: grammar, listening, reading, writing, ielts, toeic